Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.

ABSTRACT:

Background

Black men and men with end-stage kidney disease have lower rates of treatment and higher mortality for prostate cancer. We studied the interaction of end-stage kidney disease (ESKD) with Black race for treatment rates and mortality for men with prostate cancer.

Methods and results

We included 516 Black and 551 White men with ESKD before prostate cancer 22,299 Black men, and 141,821 White men without ESKD who were 40 years or older from the Surveillance, Epidemiology, and End-Results-Medicare data (2004-2016). All Black men with or without ESKD and White men with ESKD had higher prostate-specific antigen levels at diagnosis than White men without ESKD. Black men with ESKD had the lowest rates for treatment in both local and advanced stages of prostate cancer (age-a

SUBMITTER: Sarabu N 

PROVIDER: S-EPMC11106677 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature